Abstract
Our limited understanding of the neurobiological processes underlying schizophrenia has contributed to stalling the development of new treatments. The identification of genes associated with schizophrenia through the examination of rare variants is considered a promising approach to uncovering new pathophysiological processes and therapeutic targets. SCHEMA identified 32 risk genes by ana…